A Phase 3,8-week Clinical Trial to Test the Efficacy of CHF1535 Via NEXT DPI Versus Same Dose of CHF1535 pMDI and Beclomethasone DPI 100microgram on PEF in Adult Asthmatic Patients After 1 Month of Treatment With FOSTER.

Trial Profile

A Phase 3,8-week Clinical Trial to Test the Efficacy of CHF1535 Via NEXT DPI Versus Same Dose of CHF1535 pMDI and Beclomethasone DPI 100microgram on PEF in Adult Asthmatic Patients After 1 Month of Treatment With FOSTER.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Beclometasone/formoterol (Primary) ; Beclometasone
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Acronyms Neptune
  • Most Recent Events

    • 28 Apr 2012 Additional trial locations identified as reported by European Clinical Trials Database.
    • 14 Feb 2012 Actual patient number changed from 900 to 9320 according to ClinicalTrials.gov.
    • 14 Dec 2011 Actual end date Aug 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top